Morbidity of Conventional and No-touch Saphenectomy in Coronary Artery Bypass Grafting.

Launched by INSTITUTO NACIONAL DE CIRUGIA CARDIACA, URUGUAY · Jul 8, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two different surgical methods for removing a vein from the leg, known as the internal saphenous vein, which is used in heart bypass surgery. The goal is to see if one method, called "no-touch saphenectomy," is as safe and effective as the traditional method. This is important because choosing the right technique could help reduce complications and improve recovery for patients undergoing heart surgery.

To participate in this trial, you must be between 65 and 75 years old and scheduled for heart surgery that requires using the internal saphenous vein. Unfortunately, people with certain conditions such as severe obesity, poor blood sugar control, or chronic issues with veins in the legs cannot join. If you qualify and decide to take part, you will be monitored closely to ensure your safety and to gather information about how well each surgical method works in real-life situations. This study is currently recruiting participants, so if you or someone you know is interested, it might be worth discussing with a doctor.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients undergoing coordination coronary revascularization surgery, in which it is necessary to use the internal saphenous vein as a conduit.
• Exclusion Criteria:
• • Emergency surgeries.
• • Poor metabolic control (HbA1c \> 6.5%).
• • Chronic venous insufficiency or chronic obstructive arteriopathy of the lower limbs.
• • Type II obesity (BMI\>35).